Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-17

Clinical Trial Update: GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update reports results of GLP-1 therapy for weight loss and improved glucose tolerance in obese children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLP-1 Therapy

Snippet

Sponsor: University of Minnesota | Conditions: Obesity, Morbid | Phase 2 | Status: COMPLETED | Results posted: 2012-08-17